Business Description
Unicycive Therapeutics Inc
NAICS : 325110
SIC : 2834
ISIN : US90466Y1038
Share Class Description:
UNCY: Ordinary SharesDescription
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 65.9 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -73.4 | |||||
3-Year EPS without NRI Growth Rate | -48.2 | |||||
3-Year FCF Growth Rate | -63.7 | |||||
3-Year Book Growth Rate | 21.5 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.38 | |||||
9-Day RSI | 51.91 | |||||
14-Day RSI | 47.33 | |||||
6-1 Month Momentum % | -71.08 | |||||
12-1 Month Momentum % | -40.61 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.37 | |||||
Quick Ratio | 3.37 | |||||
Cash Ratio | 3.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -43.4 | |||||
Shareholder Yield % | -0.49 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -3209.19 | |||||
ROE % | -195.2 | |||||
ROA % | -75.65 | |||||
ROIC % | -188.33 | |||||
ROC (Joel Greenblatt) % | -2914.7 | |||||
ROCE % | -187.35 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 13.07 | |||||
EV-to-EBIT | -1.76 | |||||
EV-to-EBITDA | -1.79 | |||||
EV-to-Revenue | 60.31 | |||||
EV-to-Forward-Revenue | 35.11 | |||||
EV-to-FCF | -1.88 | |||||
Price-to-Net-Cash | 0.57 | |||||
Earnings Yield (Greenblatt) % | -56.82 | |||||
FCF Yield % | -62.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:UNCY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Unicycive Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.675 | ||
EPS (TTM) ($) | -1.05 | ||
Beta | 2.4 | ||
Volatility % | 118.15 | ||
14-Day RSI | 47.33 | ||
14-Day ATR ($) | 0.052542 | ||
20-Day SMA ($) | 0.370495 | ||
12-1 Month Momentum % | -40.61 | ||
52-Week Range ($) | 0.202 - 1.818 | ||
Shares Outstanding (Mil) | 94.36 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Unicycive Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Unicycive Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Unicycive Therapeutics Inc Frequently Asked Questions
What is Unicycive Therapeutics Inc(UNCY)'s stock price today?
The current price of UNCY is $0.37. The 52 week high of UNCY is $1.82 and 52 week low is $0.20.
When is next earnings date of Unicycive Therapeutics Inc(UNCY)?
The next earnings date of Unicycive Therapeutics Inc(UNCY) is 2024-11-14 Est..
Does Unicycive Therapeutics Inc(UNCY) pay dividends? If so, how much?
Unicycive Therapeutics Inc(UNCY) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |